Curesense Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 14-12-2024
- Company Age 4 Year, 24 Days
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2022)
- Profit -1704.89%
(FY 2022)
- Ebitda -463.90%
(FY 2022)
- Net Worth 14221.01%
(FY 2022)
- Total Assets 82548.96%
(FY 2022)
About Curesense Therapeutics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sujit Jain, Hasmukh Rawal, and Shailendra Kawade serve as directors at the Company.
- CIN/LLPIN
U24230PN2020PTC196328
- Company No.
196328
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Curesense Therapeutics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailendra Kawade  | Director | 26-Nov-2020 | Current |
| Hasmukh Rawal | Director | 26-Nov-2020 | Current |
| Sujit Jain | Director | 26-Nov-2020 | Current |
Financial Performance and Corporate Structure Insights of Curesense Therapeutics.
Curesense Therapeutics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1704.89% decrease in profit. The company's net worth Soared by an impressive increase of 14221.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Curesense Therapeutics?
Unlock access to Curesense Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Mylab Discovery Solutions Private LimitedActive 8 years 6 monthsSujit Jain, Hasmukh Rawal and 1 more are mutual person
4A Financial Technologies Private LimitedActive 3 years 5 monthsShailendra Kawade is a mutual person
Mylab Lifesolutions Private LimitedActive 11 years 1 monthHasmukh Rawal and Shailendra Kawade are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Curesense Therapeutics?
Curesense Therapeutics has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curesense Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curesense Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
